Detailed Information

Cited 0 time in webofscience Cited 3 time in scopus
Metadata Downloads

SPA0355 prevents ovariectomy-induced bone loss in miceopen access

Authors
Kim, Sang HoonZhang, ZhongkaiMoon, Young JaePark, Il WoonCho, Yong GonJeon, RaokPark, Byung-Hyun
Issue Date
Jan-2019
Publisher
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
Keywords
Osteoblastogenesis; Osteoclastogenesis; Osteoporosis; Ovariectomy; SPA0355
Citation
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY, v.23, no.1, pp.47 - 54
Journal Title
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY
Volume
23
Number
1
Start Page
47
End Page
54
URI
https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/3860
DOI
10.4196/kjpp.2019.23.1.47
ISSN
1226-4512
Abstract
Estrogen withdrawal in post-menopausal women leads to overactivation of osteoclasts, which contributes to the development of osteoporosis. Inflammatory cytokines are known as one of mechanisms of osteoclast activation after estrogen deficiency. SPA0355 is a thiourea derivative that has been investigated for its anti-oxidant and anti-inflammatory activities. However, its efficacy in bone resorption has not been previously investigated. The aim of this study was to investigate the impact of SPA0355 on the development of osteoporosis and to explore its mode of action. In vitro experiments showed that SPA0355 inhibited receptor activator of NF-kappa B ligand (RANKL)-induced osteoclastogenesis in primary bone marrow-derived macrophages. This effect appears to be independent of estrogen receptor activation as ICI 180,782 failed to abrogate its effects on osteoclasts. Further signaling studies revealed that SPA0355 suppressed activation of the MAPKs, Akt, and NF-kappa B pathways. SPA0355 also increased osteoblastic differentiation, as evidenced by its effects on alkaline phosphatase activity and mineralization nodule formation. Intraperitoneal administration of SPA0355 to ovariectomized mice prevented bone loss, as verified by three-dimensional images and bone morphometric parameters derived from mu CT analysis. Noticeably, SPA0355 did not show hepatotoxicity and nephrotoxicity and also had little effect on hematological parameters. Taken together, the results indicate that SPA0355 may protect against bone loss in ovariectomized mice by stimulation of osteoblast differentiation and by inhibition of osteoclast resorption. Therefore, SPA0355 is a safe and potential candidate for management of postmenopausal osteoporosis.
Files in This Item
Go to Link
Appears in
Collections
약학대학 > 약학부 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Related Researcher

Researcher Jeon, Ra Ok photo

Jeon, Ra Ok
약학대학 (약학부)
Read more

Altmetrics

Total Views & Downloads

BROWSE